This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Stiegel R., Desantis C., Jemal A.: Colorectal cancer statistics, 2014. CA. Cancer J. Clin., 2014; 64: 104-117.StiegelR.DesantisC.JemalA.Colorectal cancer statistics, 201420146410411710.3322/caac.21220Search in Google Scholar
Hanahan D., Weinberg R.A.: Hallmarks of cancer: The next generation. Cell, 2011; 144: 646–674.HanahanD.WeinbergR.A.Hallmarks of cancer: The next generation201114464667410.1016/j.cell.2011.02.013Search in Google Scholar
Vaupel P., Thews O., Hoeckel M.: Treatment resistance of solid tumors: role of hypoxia and anemia. Med. Oncol., 2001; 18: 243–259.VaupelP.ThewsO.HoeckelM.Treatment resistance of solid tumors: role of hypoxia and anemia200118243–25910.1385/MO:18:4:243Search in Google Scholar
Chen C., Pore N., Behrooz A., Ismail-Beigi F., Maity A.: Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem., 2001; 276: 9519-9525.ChenC.PoreN.BehroozA.Ismail-BeigiF.MaityA.Regulation of glut1 mRNA by hypoxia-inducible factor-120012769519952510.1074/jbc.M01014420011120745Search in Google Scholar
Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V.: HIF-1-me-diated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab., 2006; 3: 177–185.KimJ.W.TchernyshyovI.SemenzaG.L.DangC.V.HIF-1-me-diated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia2006317718510.1016/j.cmet.2006.02.00216517405Search in Google Scholar
Semenza G.L., Jiang B.H., Leung S.W., Passantino R., Concordet J.P., Maire P., Giallongo A.: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem., 1996; 271: 32529–32537.SemenzaG.L.JiangB.H.LeungS.W.PassantinoR.ConcordetJ.P.MaireP.GiallongoA.Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 11996271325293253710.1074/jbc.271.51.325298955077Search in Google Scholar
Ullah M.S., Davies A.J., Halestrap A.P.: The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism. J. Biol. Chem., 2006; 281: 9030–9037.UllahM.S.DaviesA.J.HalestrapA.P.The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism20062819030903710.1074/jbc.M51139720016452478Search in Google Scholar
Dang C.V., Le A., Gao P.: MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res., 2009; 15: 6479–6483.DangC.V.LeA.GaoP.MYC-induced cancer cell energy metabolism and therapeutic opportunities2009156479648310.1158/1078-0432.CCR-09-0889278341019861459Search in Google Scholar
Osthus R.C., Shim H., Kim S., Li Q., Reddy R., Mukherjee M., Xu Y., Wonsey D., Lee L.A., Dang C.V.: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J. Biol. Chem., 2000; 275: 21797–21800.OsthusR.C.ShimH.KimS.LiQ.ReddyR.MukherjeeM.XuY.WonseyD.LeeL.A.DangC.V.Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc2000275217972180010.1074/jbc.C00002320010823814Search in Google Scholar
Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., Nissim I., Daikhin E., Yudkoff M., et al.: Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. USA, 2008; 1059: 18782–18787.WiseD.R.DeBerardinisR.J.MancusoA.SayedN.ZhangX.Y.PfeifferH.K.NissimI.DaikhinE.YudkoffM.et alMyc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction20081059187821878710.1073/pnas.0810199105259621219033189Search in Google Scholar
Fantin V.R., St‐Pierre J., Leder P.: Attenuation of LDH‐A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell, 2006; 9: 425–434.FantinV.R.St‐PierreJ.LederP.Attenuation of LDH‐A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance2006942543410.1016/j.ccr.2006.04.02316766262Search in Google Scholar
Gatenby R.A., Gillies R.J.: Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer, 2004; 4: 891–899.GatenbyR.A.GilliesR.J.Why do cancers have high aerobic glycolysis? Nat2004489189910.1038/nrc147815516961Search in Google Scholar
Burgman P., O’Donoghue J.A., Humm J.L., Ling C.C.: Hypoxia-induced increase in FDG uptake in MCF–7 cells. J. Nucl. Med., 2001; 42: 170–175.BurgmanP.O’DonoghueJ.A.HummJ.L.LingC.C.Hypoxia-induced increase in FDG uptake in MCF–7 cells200142170175Search in Google Scholar
Busk M., Horsman M.R., Kristjansen P.E., van der Kogel A.J., Bussink J., Overgaard J.: Aerobic glycolysis in cancers: Implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia. Int. J. Cancer, 2008; 122: 2726–2734.BuskM.HorsmanM.R.KristjansenP.E.van derKogel A.J.BussinkJ.OvergaardJ.Aerobic glycolysis in cancers: Implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia20081222726273410.1002/ijc.2344918351643Search in Google Scholar
Clavo A.C., Brown R.S., Wahl R.L.: Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J. Nucl. Med., 1995; 36: 1625–1632.ClavoA.C.BrownR.S.WahlR.L.Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia19953616251632Search in Google Scholar
Gambhir S.S.: Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer, 2002; 2: 683–693.GambhirS.S.Molecular imaging of cancer with positron emission tomography2002268369310.1038/nrc88212209157Search in Google Scholar
Mekuria A.N., Abdi A.D.: Drivers of glucose and glutamine metabolism reprogramming in tumor cells and their potential as target for cancer. J. Tumor Res., 2018; 4: 139.MekuriaA.N.AbdiA.D.Drivers of glucose and glutamine metabolism reprogramming in tumor cells and their potential as target for cancer2018413910.35248/2684-1258.18.4.139Search in Google Scholar
Phan L.M., Yeung S.C., Lee M.H.: Cancer metabolic reprogramming: Importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol. Med., 2014; 11: 1–19.PhanL.M.YeungS.C.LeeM.H.Cancer metabolic reprogramming: Importance, main features, and potentials for precise targeted anti-cancer therapies201411119Search in Google Scholar
Anastasiou D., Cantley L.C.: Breathless cancer cells get fat on glutamine. Cell Res., 2012; 22: 443–446.AnastasiouD.CantleyL.C.Breathless cancer cells get fat on glutamine20122244344610.1038/cr.2012.5329229022212478Search in Google Scholar
Metallo C.M., Gameiro P.A., Bell E.L., Mattaini K.R., Yang J., Hiller K., Jewell C.M., Johnson Z.R., Irvine D.J., Guarente L., et al.: Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature, 2011; 481: 380–384.MetalloC.M.GameiroP.A.BellE.L.MattainiK.R.YangJ.HillerK.JewellC.M.JohnsonZ.R.IrvineD.J.GuarenteL.et alReductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia201148138038410.1038/nature10602371058122101433Search in Google Scholar
Mullen A.R., Wheaton W.W., Jin E.S., Chen P.H., Sullivan L.B., Cheng T., Yang Y., Linehan W.M., Chandel N.S., DeBerardinis R.J.: Reductive carboxylation supports growth in tumor cells with defective mitochondria. Nature, 2011; 481: 385–388.MullenA.R.WheatonW.W.JinE.S.ChenP.H.SullivanL.B.ChengT.YangY.LinehanW.M.ChandelN.S.DeBerardinisR.J.Reductive carboxylation supports growth in tumor cells with defective mitochondria201148138538810.1038/nature10642326211722101431Search in Google Scholar
Graboń W., Otto-Ślusarczyk D., Baranczyk-Kuźma A.: Influence of oxygen on the Warburg effect: Do cancer cells produce lactate only from glucose? Postępy Hig. Med. Dośw., 2018; 72: 481–490.GrabońW.Otto-ŚlusarczykD.Baranczyk-KuźmaA.Influence of oxygen on the Warburg effect: Do cancer cells produce lactate only from glucose? Postępy Hig20187248149010.5604/01.3001.0012.0684Search in Google Scholar
Son J., Lyssiotis C.A., Ying H., Wang X., Ligorio M., Ligorio M., Perera R.M., Ferrone C.R., Mullarky E., Shyh-Chang N., et al.: Glutamine supports pancreatic cancer growth through a KRAS-regulated matabolic pathway. Nature, 2013; 496: 101–105.SonJ.LyssiotisC.A.YingH.WangX.LigorioM.LigorioM.PereraR.M.FerroneC.R.MullarkyE.Shyh-ChangN.et alGlutamine supports pancreatic cancer growth through a KRAS-regulated matabolic pathway201349610110510.1038/nature12040365646623535601Search in Google Scholar
Nicco C., Laurent A., Chreau C., Weill B., Batteux F.: Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed. Pharmacother., 2005; 59: 169–174.NiccoC.LaurentA.ChreauC.WeillB.BatteuxF.Differential modulation of normal and tumor cell proliferation by reactive oxygen species20055916917410.1016/j.biopha.2005.03.00915862711Search in Google Scholar
Overgaad J.: Hypoxic radiosensitization: Adored and ignored. J. Clin. Oncol., 2007; 25: 4066–4074.OvergaadJ.Hypoxic radiosensitization: Adored and ignored2007254066407410.1200/JCO.2007.12.787817827455Search in Google Scholar
Gasińska A., Biesaga B.: Dwa oblicza hipoksji nowotworów. Nowotwory J. Oncol., 2010; 60: 332.GasińskaA.BiesagaB.Dwa oblicza hipoksji nowotworów201060332Search in Google Scholar
Kunz M., Ibrahim S.M.: Molecular responses to hypoxia in tumor cells. Mol. Cancer, 2003; 2: 23.KunzM.IbrahimS.M.Molecular responses to hypoxia in tumor cells200322310.1186/1476-4598-2-2315563812740039Search in Google Scholar
Macheda M.W., Rogers S., Best J.D.: Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell Physiol., 2005; 202: 654–662.MachedaM.W.RogersS.BestJ.D.Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer200520265466210.1002/jcp.2016615389572Search in Google Scholar
Medina R.A., Owen G.I.: Glucose transporters: Expression, regulation and cancer. Biol. Res., 2002; 35: 9–26.MedinaR.A.OwenG.I.Glucose transporters: Expression, regulation and cancer20023592610.4067/S0716-9760200200010000412125211Search in Google Scholar
Chung F.Y., Hyang M.Y., Yeh C.S, Chang H.J., Cheng T.L., Yen L.C., Wang J.Y., Lin S.R.: GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer., 2009; 9: 241.ChungF.Y.HyangM.Y.YehC.SChangH.J.ChengT.L.YenL.C.WangJ.Y.LinS.R.GLUT1 gene is a potential hypoxic marker in colorectal cancer patients2009924110.1186/1471-2407-9-241Search in Google Scholar
Evans S.M., Koch C.J.: Prognostic significance of tumor oxygenation in humans. Cancer Lett. 2003; 195: 1–16.EvansS.M.KochC.J.Prognostic significance of tumor oxygenation in humans200319511610.1016/S0304-3835(03)00012-0Search in Google Scholar
Li F., Wang Y., Zeller K.I., Potter J.J., Wonsey D.R., O’Donnell K.A., Kim J.W., Yustein J.T., Lee L.A., Dang C.V.: Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol., 2005; 25: 6225–6234.LiF.WangY.ZellerK.I.PotterJ.J.WonseyD.R.O’DonnellK.A.KimJ.W.YusteinJ.T.LeeL.A.DangC.V.Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis2005256225623410.1128/MCB.25.14.6225-6234.2005116879815988031Search in Google Scholar
Morrish F., Hockenberry D.: MYC and mitochondrial biogenesis. Cold Spring Harb Perspect. Med., 2014; 4: a014225.MorrishF.HockenberryD.MYC and mitochondrial biogenesis20144a01422510.1101/cshperspect.a014225399637424789872Search in Google Scholar
DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., Thompson C.B.: Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA, 2007;104: 19345–19350.DeBerardinisR.J.MancusoA.DaikhinE.NissimI.YudkoffM.WehrliS.ThompsonC.B.Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis2007104193451935010.1073/pnas.0709747104214829218032601Search in Google Scholar
Matsuno T., Goto I.: Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma. Cancer Res., 1992; 52: 1192–1194.MatsunoT.GotoI.Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma19925211921194Search in Google Scholar
Pérez-Gómez C., Campos-Sandoval J.A., Alonso F.J., Segura J.A., Manzanares E., Ruiz-Sánchez P., González M.E., Márquez J., Matés J.M.: Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem. J., 2005; 386: 535–542.Pérez-GómezC.Campos-SandovalJ.A.AlonsoF.J.SeguraJ.A.ManzanaresE.Ruiz-SánchezP.GonzálezM.E.MárquezJ.MatésJ.M.Co-expression of glutaminase K and L isoenzymes in human tumour cells200538653554210.1042/BJ20040996113487215496140Search in Google Scholar
Qie S., Chu C., Li W., Wang C., Sang N.: ErbB2 activation upregulated glutaminase 1 expression which promotes breast cancer cell proliferation. J. Cell. Biochem., 2014; 115: 498–509.QieS.ChuC.LiW.WangC.SangN.ErbB2 activation upregulated glutaminase 1 expression which promotes breast cancer cell proliferation201411549850910.1002/jcb.24684451887324122876Search in Google Scholar
Su L., Li J., Yang J., Shi J., Yu D., Ding Y.: Expression of glutaminase 1 gene in breast cancer and its clinical significance in neoadjuvant chemotherapy. Int. J. Clin. Exp. Pathol., 2016; 9: 9311–9317.SuL.LiJ.YangJ.ShiJ.YuD.DingY.Expression of glutaminase 1 gene in breast cancer and its clinical significance in neoadjuvant chemotherapy2016993119317Search in Google Scholar
Otto-Ślusarczyk D., Graboń W., Barańczyk-Kuźma A.: Pattern of glutaminase expression in primary colorectal cancer. J. Med. Brasovea, 2010; 2010: 40–43.Otto-ŚlusarczykD.GrabońW.Barańczyk-KuźmaA.Pattern of glutaminase expression in primary colorectal cancer201020104043Search in Google Scholar
Huang F., Zhang Q., Ma H., Lv Q., Zhang T.: Expression of glutaminase is upregulated in colorectal cancer and of clinical significance. Int. J. Clin. Exp. Pathol., 2014; 7: 1093–1100.HuangF.ZhangQ.MaH.LvQ.ZhangT.Expression of glutaminase is upregulated in colorectal cancer and of clinical significance2014710931100Search in Google Scholar
Xiang L., Mou J., Shao B., Wei Y., Liang H., Takano N., Semenza G.L., Xie G.: Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization. Cell Death Dis., 2019; 10: 40.XiangL.MouJ.ShaoB.WeiY.LiangH.TakanoN.SemenzaG.L.XieG.Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization2019104010.1038/s41419-018-1291-5642685330674873Search in Google Scholar
Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., Zeller K.I., De Marzo A.M., Van Eyk J.E., Mendell J.T., Dang C.V.: c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature, 2009; 458: 762–765.GaoP.TchernyshyovI.ChangT.C.LeeY.S.KitaK.OchiT.ZellerK.I.De MarzoA.M.VanEyk J.E.MendellJ.T.DangC.V.c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism200945876276510.1038/nature07823272944319219026Search in Google Scholar
Corn P.G., Ricci M.S., Scata K.A., Arsham A.M., Simon M.C., Dicker D.T., EL-Deiry W.S.: Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc induced apoptosis. Cancer Biol. Ther., 2005; 4: 1285–1294.CornP.G.RicciM.S.ScataK.A.ArshamA.M.SimonM.C.DickerD.T.EL-DeiryW.S.Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc induced apoptosis200541285129410.4161/cbt.4.11.229916319523Search in Google Scholar
Dang C.V., Kim J.W., Gao P., Yustein J.: The interplay between MYC and HIF in cancer. Nat. Rev. Cancer, 2008; 8: 51–56.DangC.V.KimJ.W.GaoP.YusteinJ.The interplay between MYC and HIF in cancer20088515610.1038/nrc227418046334Search in Google Scholar
Zhang H., Gao P., Fukuda R., Kumar G., Krishnamachary B., Zeller K.I., Dang C.V., Semenza G.L.: HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell, 2007; 11: 407–420.ZhangH.GaoP.FukudaR.KumarG.KrishnamacharyB.ZellerK.I.DangC.V.SemenzaG.L.HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity20071140742010.1016/j.ccr.2007.04.00117482131Search in Google Scholar
Altman B.J., Stine Z.E., Dang C.V.: From Krebs to clinic: Glutamine metabolism to cancer therapy. Nat. Rev. Cancer, 2016; 16: 619–634.AltmanB.J.StineZ.E.DangC.V.From Krebs to clinic: Glutamine metabolism to cancer therapy20161661963410.1038/nrc.2016.71548441527492215Search in Google Scholar
Kovacević Z., Brkljac O., Bajin K.: Control and function of the transamination pathways of glutamine oxidation in tumour cells. Biochem J., 1991; 273: 271–275.KovacevićZ.BrkljacO.BajinK.Control and function of the transamination pathways of glutamine oxidation in tumour cells199127327127510.1042/bj273027111498411991025Search in Google Scholar
Graboń W., Otto-Ślusarczyk D., Chrzanowska A., Mielczarek-Puta M., Joniec-Maciejak I., Słabik K., Barańczyk-Kuźma A.: Lactate formation in primary and metastatic colon cancer cell at hypoxia and normoxia. Cell Biochem. Funct., 2016; 34: 483–490.GrabońW.Otto-ŚlusarczykD.ChrzanowskaA.Mielczarek-PutaM.Joniec-MaciejakI.SłabikK.Barańczyk-KuźmaA.Lactate formation in primary and metastatic colon cancer cell at hypoxia and normoxia20163448349010.1002/cbf.321127528248Search in Google Scholar
Possemato R., Marks K.M., Shaul Y.D., Pacold M.E., Kim D., Birsoy K., Sethumadhavan S., Woo H.K., Jang H.G., Jha A.K., et al.: Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature, 2011; 476: 346–350.PossematoR.MarksK.M.ShaulY.D.PacoldM.E.KimD.BirsoyK.SethumadhavanS.WooH.K.JangH.G.JhaA.K.et alFunctional genomics reveal that the serine synthesis pathway is essential in breast cancer201147634635010.1038/nature10350335332521760589Search in Google Scholar
Li C., Zhang G., Zhao L., Ma Z., Chen H.: Metabolic reprogramming in cancer cells: Glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. World J. Surg. Oncol., 2016; 14: 15.LiC.ZhangG.ZhaoL.MaZ.ChenH.Metabolic reprogramming in cancer cells: Glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer2016141510.1186/s12957-016-0769-9472111626791262Search in Google Scholar
Sun R.C., Denko N.C.: Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metab., 2014; 19: 285–292.SunR.C.DenkoN.C.Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth20141928529210.1016/j.cmet.2013.11.022392058424506869Search in Google Scholar
Vatrinet R., Leone G., De Luise M., Girolimetti G., Vidone M., Gasparre G., Porcelli A.M.: The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity. Cancer Metab., 2017; 5: 3.VatrinetR.LeoneG.De LuiseM.GirolimettiG.VidoneM.GasparreG.PorcelliA.M.The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity20175310.1186/s40170-017-0165-0528901828184304Search in Google Scholar
Jiang L., Shestov A.A., Swain P., Yang C., Parker S.J., Wang Q.A., Terada L.S., Adams N.D., McCabe M.T., Pietrak B., et al.: Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature, 2016; 532: 255–258.JiangL.ShestovA.A.SwainP.YangC.ParkerS.J.WangQ.A.TeradaL.S.AdamsN.D.McCabeM.T.PietrakB.et alReductive carboxylation supports redox homeostasis during anchorage-independent growth201653225525810.1038/nature17393486095227049945Search in Google Scholar
Waters A., Zhdanov A., Papkovsky D.: Regulation of pyruvate dehydrogenase phosphorylation by hypoxia. FASEB J., 2014; 28: 572.4.WatersA.ZhdanovA.PapkovskyD.Regulation of pyruvate dehydrogenase phosphorylation by hypoxia201428572410.1096/fasebj.28.1_supplement.572.4Search in Google Scholar
Lin C.S., Liu L.T., Ou L.H., Pan S.C., Lin C.I., Wei Y.H.: Role of mitochondrial function in the invasiveness of human colon cancer cells. Oncol. Rep., 2018; 39: 316–330.LinC.S.LiuL.T.OuL.H.PanS.C.LinC.I.WeiY.H.Role of mitochondrial function in the invasiveness of human colon cancer cells20183931633010.3892/or.2017.608729138850Search in Google Scholar
Fiermonte G., Palmieri L., Todisco S., Agrimi G., Palmieri F., Walker J.E.: Identification of the mitochondrial glutamate transporter. Bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms. J. Biol. Chem., 2002; 277: 19289–19294.FiermonteG.PalmieriL.TodiscoS.AgrimiG.PalmieriF.WalkerJ.E.Identification of the mitochondrial glutamate transporter2002277192891929410.1074/jbc.M20157220011897791Search in Google Scholar
Molinari F., Raas-Rothschild A., Rio M., Fiermonte G., Encha-Razavi F., Palmieri L., Palmieri F., Ben-Neriah Z., Kadhom N., Vekemans M., et al.: Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am. J. Hum. Genet., 2005; 76: 334–339.MolinariF.Raas-RothschildA.RioM.FiermonteG.Encha-RazaviF.PalmieriL.PalmieriF.Ben-NeriahZ.KadhomN.VekemansM.et alImpaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy20057633433910.1086/427564119637815592994Search in Google Scholar
Palmieri F.: The mitochondrial transporter family SLC25: Identification, properties and physiopathology. Mol. Aspects Med., 2013; 34: 465–484.PalmieriF.The mitochondrial transporter family SLC25: Identification, properties and physiopathology20133446548410.1016/j.mam.2012.05.00523266187Search in Google Scholar
Slater C., De La Mare J.A., Edkins A.L.: In vitro analysis of putative cancer stem cell populations and chemosensitivity in the SW480 and SW620 colon cancer metastasis model. Oncol. Lett., 2018; 15: 8516–8526.SlaterC.De LaMare J.A.EdkinsA.L.In vitro analysis of putative cancer stem cell populations and chemosensitivity in the SW480 and SW620 colon cancer metastasis model2018158516852610.3892/ol.2018.8431595052429805588Search in Google Scholar